UC Pancreatic Cancer Consortium


clinical trials

Pancreas Cancer Clinical Trials across the UC System

upcoming events

UCPCC Seminar Series

and upcoming Symposia

funding opportunities

Open opportunities are listed below


UC Pancreatic Cancer Consortium Symposium

Pancreatic Cancer Screening in asymptomatic individuals with genetic susceptibility: state of the art and future directions


8:30 AM – 12:30 PM PT

Keynote Speaker: Dr. Mimi Canto, Johns Hopkins University


UCPCC Seminar Series

August 3, 2021 8:00-9:00 AM

Speaker: Silke Paust (Scripps Research)

A Novel Immunocompetent PDX Model for Preclinical Testing of Pancreatic Cancer Therapies

Join the meeting using this link


August 19, 2021 8:00-9:00 AM

Speaker: Mark O’Hara (University of Pennsylvania)

CAR T cell combination strategies in pancreatic cancer

Join the meeting using this link

September 7, 2021 8:00-9:00 AM

Speaker: Matthew Vander Heiden (MIT)

How metabolism impacts pancreatic cancer progression

Join the meeting using this link


September 16, 2021 8:00-9:00 AM

Speaker: Elizabeth Jaffee (Johns Hopkins University)

Turning the Heat Up on Pancreatic Cancer:  Lessons on Overcoming a “Cold” Immunologic Tumor Micro-environment

Join the meeting using this link


Who We Are

The mission of the UC Pancreatic Cancer Consortium (UCPCC) is to unite scientists and clinicians across the UC cancer centers committed to pancreatic cancer research and treatment in a highly collaborative environment that accelerates the progress and impact of our work.

Our vision is to improve the lives of persons diagnosed with pancreatic cancer by translating innovative research into improved clinical care.

UCPCC UC Leaders: 
UC Davis Comprehensive Cancer Center – Richard Bold
UCI Health Chao Family Comprehensive Cancer Center – Murray Korc
UCLA Jonsson Comprehensive Cancer Center – Timothy Donahue
UC San Diego Moores Cancer Center – Andrew Lowy
UCSF Helen Diller Family Comprehensive Cancer Center – Margaret Tempero





Left to right; Dr’s Richard Bold, Andrew Lowy, Margaret Tempero, Tannishtha Reya, Julie Sutcliffe and Katie Couric at the Stand Up To Cancer 2019 Scientific Summit in Santa Monica, CA.

David Dawson (UCLA)
Chang-il Hwang (UC Davis)
Alfredo Molinolo (UCSD)
Scott VandenBerg (UCSF)  

Early Biology:                                         

Guido Eibl (UCLA)
Michael Karin (UCSD)
Rushika Perera (UCSF)


Early Detection:
Gobind Anand (UCSD)
Mustafa Arain (UCSF)

Amie Blanco (UCSF)
Richard Bold (UC Davis)
Paige Bracci (UCSF)
Kenneth Chang (UCI)

Sun-Chuan Dai (UCSF)

Dena Goldberg (UCSF)
Stephen Kim (UCLA)
Kimberly Kirkwood (UCSF)
Venkataraman (Raman) Muthusamy (UCLA)
Jason Samarasena (UCI)



Johannes Czernin (UCLA)
Michael Hahn (UCSD)
Julie Sutcliffe (UC Davis)
Zhen (Jane) Wang (UCSF)


Inherited Susceptibility:     

Amie Blanco (UCSF)                          

Julia Carnevale (UCSF)
Luis Carvajal-Carmona (UC Davis)
Wendy Conlon (UCLA)

Dena Goldberg (UCSF)
Lisa Madlensky (UCSD)


PDAC Clinical Trials:
Sepideh Gholami (UC Davis)
Edward Kim (UC Davis)
Andrew Ko (UCSF)
Aaron M. Miller (UCSD)
Hitendra (Hiten) Patel (UCSD)
Caius Radu (UCLA)
Zev Wainberg (UCLA)
Martin Allen-Auerbach (UCLA)
Emily Bergsland (UCSF)
Johannes Czernin (UCLA) 
Paul Fanta (UCSD)
Cameron Foster (UC Davis)
Randy (Joel) Hecht (UCLA)
Thomas Hope (UCSF)
Nancy Joseph (UCSF)
Edward Kim (UC Davis)

Karen E. Matsukuma (UC Davis)

Eric Nakakura (UCSF)

Julie Sutcliffe (UC Davis)

Robert Warren (UCSF)

Ronald Wolf (UCI)
Technology Assessment:
Eric Collisson (UCSF)
John McPherson (UC Davis)

UC Pancreatic Cancer Consortium Working Groups:

Funding Opportunities


Copyright 2021 © Regents of the University of California